speb/financial-data huggingface dataset:
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2482157000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Insurance And Claims: 21169511000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Interest Expense: 6264532000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Interest Income: 5121649000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -544071000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 3435414000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 20576851000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -9387899000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 50997794000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Investments And Advances: 50998225000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 431000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 139472000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2696000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 7579518000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -21278494000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 431000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 970977000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 6197665000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Minority Interests: -30816862000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 139472000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Net Debt: 3027474000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -11000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Net Income: 869311000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 869311000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 31686173000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 869311000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 869311000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 32586329000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 31686173000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Net Interest Income: -1142883000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -13372410000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -21278494000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -21278494000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 1085223000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 931731000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Net PPE: 1514421000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -396614000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 0.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 20074743000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 6154816000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Normalized Income: -31469492752.56
RELIGARE.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 15059610000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Operating Revenue: 36928811000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 323559463.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 439397000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 404904000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -31849981000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1426956000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Other Payable: 5003698000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Other Properties: 74527000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Other Special Charges: -32894107000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Payables: 9933477000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 255537000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Pretax Income: 32586329000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -664024000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -23151240000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -403992000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Receivables: 5812697000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 561455000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 572253000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -21278494000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -43267745000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 9778830000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 7378000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 4111999000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 5205146000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Share Issued: 323559463.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 0.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Special Income Charges: 33101449000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: -50318000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 20576851000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 20074743000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 918696247.44
RELIGARE.NS income_statement (annual, 2023-03-31) — Tax Provision: 900156000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.03
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 2194943000.00
RELIGARE.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -668136000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Total Assets: 80938939000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 20576851000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Total Debt: 7579518000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 26774516000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 54164423000.00
RELIGARE.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 188403000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 33257500000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 33257500000.00
RELIGARE.NS income_statement (annual, 2023-03-31) — Write Off: -207342000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — +Operating Expense: -14209769000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — +Total Revenue: 8377332000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 9878362000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1416619000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1259870000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 47206283000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -130035000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Amortization: 183183000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 183183000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 29823446000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Average Dilution Earnings: -3797000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 326706819.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Basic EPS: 7.13
RELIGARE.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 2051522000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1386383000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -214082000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 987101000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 3297212000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 2009500000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 13737470000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 51588509000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 50552000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1958948000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -22864000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -2140558000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 2493354000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Change In Payable: 4536272000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 2654392000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 14715229000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -42582000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Common Stock: 3297212000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 23431412000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 383020000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1273000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 21173212000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Current Assets: 57362707000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Current Debt: 3438901000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 3631949000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Assets: 0.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 63000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 61458322000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 29089379000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 10078000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Depreciation: 717040000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 717040000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 717040000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 533857000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 328887008.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Diluted EPS: 7.07
RELIGARE.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 2325306000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 41672000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — EBIT: 5387918000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — EBITDA: 6104958000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 0.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — End Cash Position: 2009500000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2522879000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -1558522000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 14782162000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -165510000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -2602000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 240016000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 753154000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Goodwill: 117153000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 457330000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1546654000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 2468497000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Gross Profit: -12795880000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Insurance And Claims: 30754368000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Interest Expense: 911052000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 911052000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Interest Income: 739042000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 739042000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -378268000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 4859317000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Inventory: 26182000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 26870313000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -13480304000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 29823446000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Investments And Advances: 67244893000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 431000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 383020000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 2696000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 794053000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 0.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 794053000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 431000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 98623000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1079418000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 8314804000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Minority Interests: -1145014000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -30000000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 383020000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Net Debt: 1429401000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -52000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Net Income: 2329103000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 2329103000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 3474117000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 2329103000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 2329103000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 4476866000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 3474117000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Net Interest Income: -379541000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -18140867000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 283482000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 283482000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -1472349000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -2652259000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Net PPE: 1208627000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -210426000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 22974082000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 510512000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 20730000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1141463000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2989831000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Normalized Income: -88283552.97
RELIGARE.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 14996244000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Operating Income: 1413889000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Operating Revenue: 8377332000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 329721163.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 560000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 2022785000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 47926000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 340177000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -6404116000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 392937000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 35098000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 329770000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 37445535000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Payable: 4908135000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Properties: 76776000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 2227563000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 49579009000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Other Special Charges: -2298565000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Payables: 14786497000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 304982000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Pretax Income: 4476866000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -1283491000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -30000000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -25456216000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -214082000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Receivables: 4359173000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 21173212000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 717040000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 193217000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 193217000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -41445900000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 7315349000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 3656000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1791003000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2544157000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Share Issued: 329721163.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Special Income Charges: 3115127000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: -7307000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 23431412000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 22974082000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 697740447.03
RELIGARE.NS income_statement (annual, 2024-03-31) — Tax Provision: 1002749000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.22
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 81049000.00
RELIGARE.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -215127000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Assets: 94736070000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 23431412000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Debt: 4426002000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 31746216000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Total Expenses: 6963443000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 62989854000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 37373363000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1531532000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 207531000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 63000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 3115127000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 3115127000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 13626000.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
RELIGARE.NS balance_sheet (annual, 2024-03-31) — Working Capital: -4095615000.00
RELIGARE.NS income_statement (annual, 2024-03-31) — Write Off: -816562000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 11274412000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 78583423000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 3302952000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 10275396000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Federal Funds Sold: 10275396000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 10275396000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 3302952000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 24509093000.00
RELIGARE.NS income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: -3697000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 117153000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 411198000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 1154713000.00
RELIGARE.NS income_statement (quarterly, 2024-09-30) — Interest Income: 1758211000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 24509093000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 78583423000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 78583423000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 2056531000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 8822897000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 1154713000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 24097895000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 330295163.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 21206141000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 294045000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Other Payable: 2143195000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 1154713000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Payables: 13704136000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Receivables: 2468849000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 330295163.00
RELIGARE.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 24509093000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 24097895000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 1128076000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 102761308000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 24509093000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2056531000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 33331990000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 69429318000.00
RELIGARE.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 286529000.00
RELIGARE.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: -3697000.00
RELIGARE.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -3697000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 5999950000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 6538000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 10636064000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 51232000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Interest Income: 1775514000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -51232000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Operating Income: -755600000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 17791000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 5999950000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 17391614000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 6538000.00
RELIGARE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 6538000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — +Operating Expense: 45353724000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 11341499000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — +Total Revenue: 73290987000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 20221098000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 14368867000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 14368867000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 849024000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 849024000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 47295355000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 47295355000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -132939000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -132939000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Amortization: 145717000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 19949000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 80297829000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 80297829000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Average Dilution Earnings: -1956000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 328815831.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 328278667.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Basic EPS: 3.79
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 2009500000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -248865000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 951962000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 951962000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 3306537000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3306537000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 3026680000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3026680000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 10867402000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 10867402000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 20814346000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 20814346000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 55638000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 55638000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 2971042000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 2971042000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -2014000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -221805000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 8694049000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Change In Payable: 4175449000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 2665947000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 19230822000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 532680000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Common Stock: 3306537000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 3306537000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 25158230000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 25158230000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 46413000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 19662000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 19662000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 25406032000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6680240000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Current Assets: 26652736000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 26652736000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 209440000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1378214000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1378214000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1587654000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1587654000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Assets: 440246000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Assets: 440246000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 513805000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 513805000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 75837947000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 75837947000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 33027983000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 33027983000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Depreciation: 600055000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 620004000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 620004000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 173456000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 620004000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 173456000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 329685714.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 330481879.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Diluted EPS: 3.78
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.98
RELIGARE.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1246212000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 984836000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 47311000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — EBIT: 2804381000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — EBIT: 2279016000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — EBITDA: 3424385000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — EBITDA: 2452472000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — End Cash Position: 2542180000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -2854847000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 14985805000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -267102000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -2054000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 3477000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -6330000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Goodwill: 97204000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 97204000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 364260000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 364260000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 981963000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 981963000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 1081019000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1081019000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Gross Profit: 47884955000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 13540858000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Interest Expense: 371380000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 57902000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 371380000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 57902000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Interest Income: 654432000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Interest Income: -4668279000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 654432000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -533272000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 6340643000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Inventory: 28196000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 28196000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 26540574000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 26540574000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -11847143000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 80297829000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 90244773000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Investments And Advances: 90244773000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 90244773000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 46413000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 742522000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 742522000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 4130000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4130000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 746652000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 746652000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 147416000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 147416000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 9209264000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 9209264000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Minority Interests: -581310000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -522398000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 46413000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Income: 1246212000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Income: 984836000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1246212000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 984836000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1827522000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1507234000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1246212000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 984836000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1246212000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 984836000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 2433001000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1827522000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1507234000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Interest Income: -371380000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -57902000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -17989447000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -2056557000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -2056557000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -371380000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -57902000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 61983000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 863201000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1081019000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1081019000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -245650000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -2056557000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 24793970000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 24793970000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 93945000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 93945000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1020288000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1020288000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 3424385000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2452472000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Normalized Income: 1246212000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 984836000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 15234670000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Operating Income: 2531231000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Operating Income: 2199359000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Operating Revenue: 73290987000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 20221098000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 330653663.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 330653663.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 2791271000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 8868112000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 477000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 477000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 273929000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 267056000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -5992841000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 202044000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 202044000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 273150000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 79657000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 45755004000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 11602585000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Payable: 5055438000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 5055438000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Properties: 1081019000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1138695000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1729214000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1729214000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 17787666000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 17787666000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Other Special Charges: -2054000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Payables: 19424305000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Payables: 19424305000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Pretax Income: 2433001000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 2221114000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -1457743000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -27397647000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -248865000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Receivables: 849024000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Receivables: 849024000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 25406032000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6680240000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 620004000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 173456000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 200761000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 200761000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -2056557000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -40250227000.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -40250227000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 9408200000.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 3215000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1384296000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2135874000.00
RELIGARE.NS balance_sheet (annual, 2025-03-31) — Share Issued: 330653663.00
RELIGARE.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 330653663.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 0.00
RELIGARE.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -2056557000.00
RELIGARE.NS income_statement (annual, 2025-03-31) — Special Income Charges: 104558000.00
RELIGARE.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 104558000.00